H-Index
70
Scimago Lab
powered by Scopus
Clarivate
Analytics
Formerly the IP & Science
business of Thomson Reuters

Logo




eISSN: 1643-3750

Telomere Reverse Transcriptase (TERT) rs2735940 Increases Cancer Risk

Hui Yang, Jing Li, Ruihua Tang, Yaxiong Liu, Yan Shao, Qingsheng Huang, Junling Shi

(School of Life Sciences, Northwestern Polytechnical University, Xi’an, Shanxi, China (mainland))

Med Sci Monit 2015; 21:612-616

DOI: 10.12659/MSM.893087

Published: 2015-02-26


Background: Telomerase reverse transcriptase (TERT) rs2735940 polymorphism was found to be associated with increased cancer risk. However, recent studies reported controversial results. The aim of our study was to detect its relationship with cancer risk.
Material and Methods: EMBASE and PubMed databases were searched for all publications until October 2014. ORs and 95% CIs were applied to investigate the association in the random-effects model.
Results: Thirteen case-control studies with 19385 cases and 17558 controls were included in this study. We found a significant association between cancer risk and TERT rs2735940 polymorphism (OR=1.06, 95% CI 1.02–1.11, P=0.005). In the subgroup analysis by ethnicity, a marginal association was found in Caucasians (OR=1.05, 95% CI 1.00–1.10, P=0.05), but not in Asians (OR=1.01, 95% CI 0.82–1.24, P=0.93). In the subgroup analysis by cancer site, this polymorphism was significantly associated with lung cancer risk (OR=1.08, 95% CI 1.02–1.13, P=0.004).
Conclusions: TERT rs2735940 polymorphism was significantly associated with cancer risk, especially lung cancer.

Keywords: Genetic Predisposition to Disease, Genetic Association Studies, Humans, Neoplasms - genetics, Polymorphism, Single Nucleotide - genetics, Risk Factors, Telomerase - genetics



Back